Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,450 USD | -12,84% | -22,29% | -62,87% |
Voorlopige winst- en verliesrekening: Silence Therapeutics plc
Fiscaal tijdperk: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Omzet 1 | 0,244 | 5,479 | 12,42 | 17,5 | 25,38 | 20,75 | 28,03 | 16,96 |
Variatie | - | 2.145,49% | 126,59% | 40,97% | 44,99% | -18,23% | 35,1% | -39,51% |
EBITDA 1 | -22,25 | -35,35 | -45,39 | -48,11 | -49,11 | -61,57 | -51,7 | -95,43 |
Variatie | - | 58,87% | 28,39% | 6% | 2,07% | -25,38% | 16,03% | -84,58% |
Bedrijfsresultaat (EBIT) 1 | -22,73 | -35,85 | -45,81 | -48,59 | -49,6 | -61,02 | -59,09 | -91,21 |
Variatie | - | 57,68% | 27,8% | 6,07% | 2,08% | -23,01% | 3,16% | -54,37% |
Betaalde rente | - | - | -0,052 | - | - | - | - | - |
Resultaat voor belastingen (EBT) 1 | -22,87 | -36,04 | -45,86 | -47,37 | -50,31 | -68,35 | -76,05 | -92,45 |
Variatie | - | 57,59% | 27,23% | 3,3% | 6,21% | -35,86% | -11,27% | -21,56% |
Nettowinst (verlies) 1 | -19,58 | -32,55 | -39,41 | -40,49 | -43,27 | -61,05 | -72,85 | -89,25 |
Variatie | - | 66,21% | 21,09% | 2,74% | 6,86% | -41,1% | -19,33% | -22,51% |
Datum van publicatie | 14/04/20 | 30/03/21 | 17/03/22 | 15/03/23 | 13/03/24 | - | - | - |
Balansprognose: Silence Therapeutics plc
Fiscaal tijdperk: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Nettoschuld 1 | -13,5 | -37,4 | -73,5 | - | -53,8 | -90,3 | -135 | -71,6 |
Variatie | - | -377,04% | -296,52% | - | - | -267,97% | -249,5% | -153,04% |
Datum van publicatie | 14/04/20 | 30/03/21 | 17/03/22 | 15/03/23 | 13/03/24 | - | - | - |
Verwachte kasstroom: Silence Therapeutics plc
Fiscaal tijdperk: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 0,009 | 0,511 | 1,311 | 0,14 | 0,045 | 1,25 | 5,35 | 10,3 |
Variatie | - | 5.577,78% | 156,56% | -89,32% | -67,86% | 2.677,78% | 328% | 92,52% |
Vrije kasstroom (FCF) 1 | - | -11,29 | 1,084 | -45,6 | -45,61 | -51,45 | -64,05 | -75,6 |
Variatie | - | - | -109,6% | -4.306,27% | 0,02% | 12,81% | 24,49% | 18,03% |
Datum van publicatie | 14/04/20 | 30/03/21 | 17/03/22 | 15/03/23 | 13/03/24 | - | - | - |
Verwachte financiële ratio's: Silence Therapeutics plc
Fiscaal tijdperk: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
EBITDA-marge (%) | -9.119,67% | -645,21% | -365,58% | -274,9% | -193,52% | -296,74% | -184,44% | -562,77% |
EBIT-marge (%) | -9.317,21% | -654,26% | -369,02% | -277,66% | -195,48% | -294,07% | -210,79% | -537,88% |
EBT-marge (%) | -9.372,95% | -657,8% | -369,36% | -270,66% | -198,27% | -329,41% | -271,29% | -545,18% |
Nettomarge (%) | -8.025,41% | -594,03% | -317,44% | -231,35% | -170,51% | -294,23% | -259,88% | -526,31% |
FCF-marge (%) | - | -206% | 8,73% | -260,53% | -179,73% | -247,96% | -228,49% | -445,82% |
Vrije kasstroom/nettoresultaat (%) | - | 34,68% | -2,75% | 112,61% | 105,41% | 84,28% | 87,92% | 84,71% |
Winstgevendheid | ||||||||
ROA | - | - | - | - | - | - | - | - |
ROE | - | -359,28% | -448,22% | - | -221,19% | -142,1% | -17,5% | -103,96% |
Financiële gezondheid | ||||||||
Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
Schuld/vrije kasstroom | - | - | - | - | - | - | - | - |
Kapitaalintensiteit | ||||||||
Kapitaaluitgaven/omzet (%) | 3,69% | 9,33% | 10,56% | 0,8% | 0,18% | 6,02% | 19,09% | 60,74% |
CAPEX / EBITDA (%) | -0,04% | -1,45% | -2,89% | -0,29% | -0,09% | -2,03% | -10,35% | -10,79% |
CAPEX / FCF (%) | - | -4,53% | 120,94% | -0,31% | -0,1% | -2,43% | -8,35% | -13,62% |
Bestanddelen per aandeel | ||||||||
Kasstroom per aandeel 1 | - | - | - | - | - | - | - | - |
Variatie | - | - | - | - | - | - | - | - |
Dividend per aandeel 1 | - | - | - | - | - | - | - | - |
Variatie | - | - | - | - | - | - | - | - |
Nettoactief per aandeel 1 | - | - | - | - | 0,5883 | 0,5549 | 1,002 | 0,368 |
Variatie | - | - | - | - | - | -5,68% | 80,6% | -63,28% |
WPA 1 | - | -1,638 | -1,742 | -1,527 | -1,491 | -0,5632 | -0,6905 | -0,6854 |
Variatie | - | - | 6,29% | -12,31% | -2,35% | -62,23% | 22,6% | -0,73% |
Aantal aandelen (in duizend) | - | 27.769 | 29.928 | 35.893 | 38.670 | 47.215 | 47.215 | 47.215 |
Datum van publicatie | - | 30/03/21 | 17/03/22 | 15/03/23 | 13/03/24 | - | - | - |
2024 * | 2025 * | |
---|---|---|
K/w-verhouding | -13,1x | -10,7x |
PBR-ratio | 13,3x | 7,38x |
EV/omzet | 8,86x | 4,96x |
Dividendrendement | - | - |